IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PATRICK R MILLER

Allopathic & Osteopathic Physicians Radiology Radiation Oncology

NPI
1023016573
CMS profile
990514
Location
GLENDALE, AZ

General Payments · PY2018–2024

$8,910.05

  • Reported across 424 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,542.21

70 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Radiation Oncology AZ All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,492.21 68
Consulting Fee $1,050.00 2

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $1,127.64 6
ABBVIE INC. $165.64 8
NOVARTIS PHARMACEUTICALS CORPORATION $128.48 7
PFIZER INC. $116.47 6
Genmab U.S., Inc. $97.53 4
GENZYME CORPORATION $84.91 3
Merck Sharp & Dohme Corporation $74.81 3
Genentech USA, Inc. $73.49 3
TerSera Therapeutics LLC $65.35 2
Blueprint Medicines Corporation $54.59 2
Incyte Corporation $54.02 3
Lilly USA, LLC $53.45 2
Janssen Biotech, Inc. $43.67 2
GlaxoSmithKline, LLC. $38.44 2
Takeda Pharmaceuticals U.S.A., Inc. $36.33 2
Ipsen Biopharmaceuticals, Inc $34.63 2
EISAI INC. $31.47 1
Regeneron Healthcare Solutions, Inc. $30.77 1
Rigel Pharmaceuticals, Inc. $28.83 1
PUMA BIOTECHNOLOGY, INC. $24.11 1
Daiichi Sankyo Inc. $22.28 1
ADC Therapeutics America, Inc. $22.08 1
E.R. Squibb & Sons, L.L.C. $21.89 1
BOSTON SCIENTIFIC CORPORATION $21.59 1
SERVIER PHARMACEUTICALS LLC $20.69 1
Gilead Sciences, Inc. $18.98 1
Coherus Biosciences Inc. $18.59 1
PROGENICS PHARMACEUTICALS, INC. $17.94 1
Bayer HealthCare Pharmaceuticals Inc. $13.54 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $866.96 60
PY2019 $823.42 44
PY2020 $708.63 45
PY2021 $1,292.47 72
PY2022 $1,432.74 75
PY2023 $1,243.62 58
PY2024 $2,542.21 70

Payment records · PY2024 (70)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $29.57 01/31/2024 Food and Beverage Undisputed 01/23/2026 1105038429 CMS
ABBVIE INC. $18.08 02/24/2024 Food and Beverage Undisputed 01/23/2026 1105038431 CMS
ABBVIE INC. $23.86 05/20/2024 Food and Beverage Undisputed 01/23/2026 1105038433 CMS
ABBVIE INC. $23.09 05/31/2024 Food and Beverage Undisputed 01/23/2026 1105038435 CMS
ABBVIE INC. $10.15 06/04/2024 Food and Beverage Undisputed 01/23/2026 1105038437 CMS
ABBVIE INC. $21.46 09/03/2024 Food and Beverage Undisputed 01/23/2026 1105038439 CMS
ABBVIE INC. $19.58 09/13/2024 Food and Beverage Undisputed 01/23/2026 1105038441 CMS
ABBVIE INC. $19.85 12/10/2024 Food and Beverage Undisputed 01/23/2026 1105038443 CMS
ADC Therapeutics America, Inc. $22.08 06/11/2024 Food and Beverage Undisputed 01/23/2026 1121191141 CMS
AstraZeneca Pharmaceuticals LP $21.31 02/20/2024 Food and Beverage Undisputed 01/23/2026 1104714609 CMS
AstraZeneca Pharmaceuticals LP $26.99 05/02/2024 Food and Beverage Undisputed 01/23/2026 1105210350 CMS
AstraZeneca Pharmaceuticals LP $525.00 10/30/2024 Consulting Fee Undisputed 01/23/2026 1104780534 CMS
AstraZeneca Pharmaceuticals LP $525.00 10/30/2024 Consulting Fee Undisputed 01/23/2026 1105822497 CMS
AstraZeneca Pharmaceuticals LP $26.59 11/15/2024 Food and Beverage Undisputed 01/23/2026 1104205943 CMS
AstraZeneca Pharmaceuticals LP $2.75 11/15/2024 Food and Beverage Undisputed 01/23/2026 1104574676 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.54 01/16/2024 Food and Beverage Undisputed 01/23/2026 1086195276 CMS
Blueprint Medicines Corporation $27.10 07/15/2024 Food and Beverage Undisputed 01/23/2026 1147441964 CMS
Blueprint Medicines Corporation $27.49 10/25/2024 Food and Beverage Undisputed 01/23/2026 1147442002 CMS
Boston Scientific Corporation $21.59 02/28/2024 Food and Beverage Undisputed 01/23/2026 1092675999 CMS
Coherus Biosciences Inc. $18.59 04/04/2024 Food and Beverage Undisputed 01/23/2026 1147275288 CMS
Daiichi Sankyo Inc. $22.28 09/05/2024 Food and Beverage Undisputed 01/23/2026 1089457558 CMS
E.R. Squibb & Sons, L.L.C. $21.89 09/16/2024 Food and Beverage Undisputed 01/23/2026 1101327570 CMS
Eisai Inc. $31.47 08/29/2024 Food and Beverage Undisputed 01/23/2026 1110771847 CMS
Genentech USA, Inc. $31.04 04/15/2024 Food and Beverage Undisputed 01/23/2026 1133085677 CMS
Genentech USA, Inc. $17.09 07/01/2024 Food and Beverage Undisputed 01/23/2026 1133085668 CMS
Genentech USA, Inc. $25.36 08/16/2024 Food and Beverage Undisputed 01/23/2026 1133085672 CMS
Genmab U.S., Inc. $30.61 02/01/2024 Food and Beverage Undisputed 01/23/2026 1126830612 CMS
Genmab U.S., Inc. $30.39 02/24/2024 Food and Beverage Undisputed 01/23/2026 1126830614 CMS
Genmab U.S., Inc. $18.53 07/01/2024 Food and Beverage Undisputed 01/23/2026 1126830616 CMS
Genmab U.S., Inc. $18.00 10/07/2024 Food and Beverage Undisputed 01/23/2026 1126830618 CMS
GENZYME CORPORATION $32.56 07/16/2024 Food and Beverage Undisputed 01/23/2026 1139627584 CMS
GENZYME CORPORATION $19.66 07/26/2024 Food and Beverage Undisputed 01/23/2026 1139627602 CMS
GENZYME CORPORATION $32.69 11/18/2024 Food and Beverage Undisputed 01/23/2026 1139627654 CMS
Gilead Sciences, Inc. $18.98 02/06/2024 Food and Beverage Undisputed 01/23/2026 1133836138 CMS
GlaxoSmithKline, LLC. $20.57 01/05/2024 Food and Beverage Undisputed 01/23/2026 1116509427 CMS
GlaxoSmithKline, LLC. $17.87 05/03/2024 Food and Beverage Undisputed 01/23/2026 1116565622 CMS
Incyte Corporation $14.90 01/23/2024 Food and Beverage Undisputed 01/23/2026 1141202277 CMS
Incyte Corporation $20.86 05/17/2024 Food and Beverage Undisputed 01/23/2026 1141279560 CMS
Incyte Corporation $18.26 10/15/2024 Food and Beverage Undisputed 01/23/2026 1141282052 CMS
Ipsen Biopharmaceuticals, Inc $17.54 03/05/2024 Food and Beverage Undisputed 01/23/2026 1091957113 CMS
Ipsen Biopharmaceuticals, Inc $17.09 09/10/2024 Food and Beverage Undisputed 01/23/2026 1091957109 CMS
Janssen Biotech, Inc. $21.22 04/11/2024 Food and Beverage Undisputed 01/23/2026 1078275655 CMS
Janssen Biotech, Inc. $22.45 07/08/2024 Food and Beverage Undisputed 01/23/2026 1078275693 CMS
Lilly USA, LLC $26.60 09/19/2024 Food and Beverage Undisputed 01/23/2026 1135318231 CMS
Lilly USA, LLC $26.85 10/17/2024 Food and Beverage Undisputed 01/23/2026 1135186673 CMS
Merck Sharp & Dohme LLC $23.17 04/05/2024 Food and Beverage Undisputed 01/23/2026 1141841595 CMS
Merck Sharp & Dohme LLC $25.65 10/11/2024 Food and Beverage Undisputed 01/23/2026 1141616126 CMS
Merck Sharp & Dohme LLC $25.99 11/12/2024 Food and Beverage Undisputed 01/23/2026 1141616036 CMS
Novartis Pharmaceuticals Corporation $17.25 02/15/2024 Food and Beverage Undisputed 01/23/2026 1087112598 CMS
Novartis Pharmaceuticals Corporation $18.33 02/26/2024 Food and Beverage Undisputed 01/23/2026 1087112594 CMS
Novartis Pharmaceuticals Corporation $14.96 03/25/2024 Food and Beverage Undisputed 01/23/2026 1087112596 CMS
Novartis Pharmaceuticals Corporation $13.42 06/04/2024 Food and Beverage Undisputed 01/23/2026 1087112606 CMS
Novartis Pharmaceuticals Corporation $18.94 08/09/2024 Food and Beverage Undisputed 01/23/2026 1087112626 CMS
Novartis Pharmaceuticals Corporation $28.01 09/10/2024 Food and Beverage Undisputed 01/23/2026 1087112618 CMS
Novartis Pharmaceuticals Corporation $17.57 09/17/2024 Food and Beverage Undisputed 01/23/2026 1087112630 CMS
PFIZER INC. $18.22 02/16/2024 Food and Beverage Undisputed 01/23/2026 1131720586 CMS
PFIZER INC. $30.68 04/02/2024 Food and Beverage Undisputed 01/23/2026 1131288687 CMS
PFIZER INC. $17.32 05/03/2024 Food and Beverage Undisputed 01/23/2026 1131732794 CMS
PFIZER INC. $15.28 06/22/2024 Food and Beverage Undisputed 01/23/2026 1131346127 CMS
PFIZER INC. $13.35 08/05/2024 Food and Beverage Undisputed 01/23/2026 1131796214 CMS
PFIZER INC. $21.62 10/31/2024 Food and Beverage Undisputed 01/23/2026 1131246935 CMS
PROGENICS PHARMACEUTICALS, INC. $17.94 03/29/2024 Food and Beverage Undisputed 01/23/2026 1128515815 CMS
PUMA BIOTECHNOLOGY, INC. $24.11 01/30/2024 Food and Beverage Undisputed 01/23/2026 1113843766 CMS
Regeneron Healthcare Solutions, Inc. $30.77 09/24/2024 Food and Beverage Undisputed 01/23/2026 1114115723 CMS
Rigel Pharmaceuticals, Inc. $28.83 10/07/2024 Food and Beverage Undisputed 01/23/2026 1145206117 CMS
SERVIER PHARMACEUTICALS LLC $20.69 05/10/2024 Food and Beverage Undisputed 01/23/2026 1147262505 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.80 04/19/2024 Food and Beverage Undisputed 01/23/2026 1144963216 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.53 08/15/2024 Food and Beverage Undisputed 01/23/2026 1144963218 CMS
TerSera Therapeutics LLC $26.72 01/29/2024 Food and Beverage Undisputed 01/23/2026 1144717531 CMS
TerSera Therapeutics LLC $38.63 10/10/2024 Food and Beverage Undisputed 01/23/2026 1144717533 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.